Private Equity 8 Hours

Last updated: May 13, 2026, 2:30 PM ET

Public Offerings & Exits

The market saw a mix of high-profile listings and strategic divestitures as private equity firms managed asset lifecycles. KKR-backed Global Medical Response successfully navigated choppy waters to list on the NYSE, raising $479M after pricing its initial public offering below the initial target range, valuing the ambulance service provider at approximately $3.3bn. Separately, American Securities finalized a sale of its processing equipment provider, CPM, to Rosebank for a substantial $2.1bn, concluding a holding period that began in 2018. In an exit move, Argosy completed its divestiture of InTech Aerospace following its acquisition by CCE Group, while William Blair is expanding its sports focus by acquiring Inner Circle Sports to bolster expertise in valuing major sports franchises amid the M&A surge.

Fundraising & Consultant Growth

Major institutional players are actively positioning for growth across credit and long-hold strategies. Blackstone is preparing its third vintage of a long-dated private equity strategy, signaling continued confidence in long-term buyout returns, while Brookfield anticipates "bumper inflows" across its funds, according to internal reports shared with LPs. In the advisory space, Lazard's acquisition of Campbell Lutyens is set to forge a combined entity whose future co-CEOs anticipate smooth integration to capture more secondaries and private capital business. Meanwhile, investment consultant Cambridge Associates is focusing on expanding its wealthy client allocations in Asia, anticipating fast growth in specialized areas like credit secondaries and specialized lending.

Venture Capital & AI Investments

Venture activity continues to concentrate on high-value AI plays, though other sectors face tightening capital, exemplified by the struggles in Agtech. Accel and Founders Fund co-led a $220M raise for Fractile, showcasing continued strong backing for emerging technology platforms. In a separate massive funding discussion, Anthropic is reportedly negotiating a staggering $30bn capital injection, which could push its valuation past $900bn, underscoring the premium placed on leading foundational AI models. Contrasting this, venture funding for agriculture-related startups in 2026 is tracking flat or lower year-over-year, with deal counts declining more sharply, despite the presence of AI-driven competitors. Furthermore, a small AI-powered staffing platform, Saile, secured $2.2M in pre-seed funding to help physicians with credentialing and finding side jobs.

Sector-Specific Deals and Litigation

Private equity firms made targeted investments across specialized industrial, life science, and travel sectors. Eir Partners backed QuartzBio, a firm providing sample and biomarker intelligence for clinical-stage biopharma companies, demonstrating continued PE interest in health technology supporting drug development. In the insurance space, Main Capital invested in Agenium, an insurtech firm offering a cloud-based platform for carriers. Travel services also saw activity, with World Travel Holdings securing investment from Citation, though the co-founders will retain substantial ownership and operational control. On the litigation front, generative AI firm ElevenLabs faces new lawsuits alleging unauthorized use of voices belonging to Pulitzer and Emmy-winning journalists, reflecting growing legal scrutiny over data sourcing in synthetic media.